CureDuchenne Venture's Early Stage Investment in Bamboo Therapeutics Accelerates Gene Therapy for Duchenne ... - Business Wire (press release)

CureDuchenne Venture's Early Stage Investment in Bamboo Therapeutics Accelerates Gene Therapy for Duchenne ... Business Wire (press release) NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Today, Pfizer Inc. announced its acquisition of Bamboo Therapeutics in a deal worth up to $645 million. Bamboo Therapeutics is an early-stage biotechnology company developing therapies for rare ... and more »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGGRVsa4zaEyU1HSZforFEpuE4o7w&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779170956749&ei=dJ-fV_CBD4SH3wG4wYOoCw&url=http://www.businesswire.com/news/home/20160801005900/en/CureDuchenne-Ventures-Early-Stage-Investment-Bamboo-Therapeutics
via IFTTT